KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $10,770,000 | -36.8% | 700,273 | -30.0% | 5.76% | -35.0% |
Q1 2014 | $17,045,000 | +31.6% | 1,000,273 | 0.0% | 8.86% | +27.1% |
Q4 2013 | $12,954,000 | -37.3% | 1,000,273 | -51.2% | 6.97% | -38.9% |
Q3 2013 | $20,672,000 | +35.1% | 2,048,773 | 0.0% | 11.42% | +0.4% |
Q2 2013 | $15,304,000 | – | 2,048,773 | – | 11.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |